Spark

ONCE NASDAQ
96.85
-1.33
-1.35%
After Hours: 96.85 0 0.00% 17:04 07/19 EDT
Open
97.90
Prev Close
98.18
High
98.99
Low
96.63
Volume
287.54K
Avg Vol (3M)
542.86K
52 Week High
114.20
52 Week Low
34.53
% Turnover
0.75%
Market Cap
3.72B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Spark ONCE stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.
MORE >

Recently

Name
Price
%Change